BetterLife Pharma Inc. (CSE:BETR)

Market Cap	10.60M -24.4%
Revenue (ttm)	n/a
Net Income	-1.85M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	403,000
Average Volume	143,216
Open	0.0600
Previous Close	0.0650
Day's Range	0.0600 - 0.0650
52-Week Range	0.0400 - 0.1200
Beta	0.49
RSI	50.43
Earnings Date	May 29, 2026

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to t...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 7
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: BETR